Back to search

Article

AGR2 – a Novel Predictor of Neoadjuvant Chemoradiotherapy Response in Esophageal Squamous Cell Carcinoma

2021-05-13

Abstract excerpt

<title>Abstract</title> <p>BackgroundEsophageal squamous cell carcinoma (ESCC) still has a poor prognosis despite the use of multidisciplinary therapy. In the locally advanced stage, neoadjuvant chemoradiotherapy (nCRT) followed by surgery might provide survival benefits to some patients. MethodsIn <italic>this study</italic>, we <italic>aimed to identify</italic> biomarker to <italic>predict</italic> tumor respo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e8164fe9-1a69-598e-9937-5cad82fe0f0f
DOI
10.21203/rs.3.rs-501001/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
AGR2 – a Novel Predictor of Neoadjuvant Chemoradiotherapy Response in Esophageal Squamous Cell CarcinomaDOI 10.21203/rs.3.rs-501001/v1
Select a neighboring publication to make it the new centre.